Provided herein is an improved, commercially viable and industrially advantageous process for the preparation of strontium ranelate, and its intermediates, in high yield and purity. Provided further herein is a highly pure strontium ranelate substantially free of impurities, and pharmaceutical compositions comprising highly pure strontium ranelate substantially free of impurities.
本文提供了一种改进的、商业上可行的和工业上有利的制备
酞酸锶及其中间体的过程,其产率和纯度高。此外,本文还提供了一种高度纯净的
酞酸锶,基本上不含杂质,并包括含有基本上不含杂质的高度纯净的
酞酸锶的制药组合物。